These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 35281438)

  • 1. Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study.
    Hoo GSR; Cai Y; Quek YC; Teo JQ; Choudhury S; Koh TH; Lim TP; Marimuthu K; Ng OT; Kwa AL
    Front Cell Infect Microbiol; 2022; 12():719421. PubMed ID: 35281438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
    Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).
    Paniagua-García M; Bravo-Ferrer JM; Pérez-Galera S; Kostyanev T; de Kraker MEA; Feifel J; Palacios-Baena ZR; Schotsman J; Cantón R; Daikos GL; Carevic B; Dragovac G; Tan LK; Raka L; Hristea A; Viale P; Akova M; Cano Á; Reguera JM; Bartoloni A; Florescu SA; Benea S; Bukarica L; Asensio Á; Korten V; Grundmann H; Goossens H; Bonten MJ; Gutiérrez-Gutiérrez B; Rodríguez-Baño J;
    Clin Microbiol Infect; 2024 Feb; 30(2):223-230. PubMed ID: 38267096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
    Muggeo A; Guillard T; Barbe C; Thierry A; Bajolet O; Vernet-Garnier V; Limelette A; Brasme L; De Champs C;
    J Antimicrob Chemother; 2017 May; 72(5):1496-1501. PubMed ID: 28158526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan.
    Lin TC; Hung YP; Lin WT; Dai W; Huang YL; Ko WC
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1122-1129. PubMed ID: 34244117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis.
    Ortiz-Brizuela E; Caro-Vega Y; Bobadilla-Del-Valle M; Leal-Vega F; Criollo-Mora E; López Luis BA; Esteban-Kenel V; Torres-Veintimilla E; Galindo-Fraga A; Olivas-Martínez A; Tovar-Calderón E; Torres-González P; Sifuentes-Osornio J; Ponce-de-León A
    J Hosp Infect; 2020 Aug; 105(4):757-765. PubMed ID: 32565368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals.
    Cai Y; Hoo GSR; Lee W; Tan BH; Yoong J; Teo YY; Graves N; Lye D; Kwa AL
    PLOS Glob Public Health; 2022; 2(12):e0001311. PubMed ID: 36962882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey.
    Cai Y; Venkatachalam I; Tee NW; Tan TY; Kurup A; Wong SY; Low CY; Wang Y; Lee W; Liew YX; Ang B; Lye DC; Chow A; Ling ML; Oh HM; Cuvin CA; Ooi ST; Pada SK; Lim CH; Tan JWC; Chew KL; Nguyen VH; Fisher DA; Goossens H; Kwa AL; Tambyah PA; Hsu LY; Marimuthu K
    Clin Infect Dis; 2017 May; 64(suppl_2):S61-S67. PubMed ID: 28475790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Carbapenem-Resistant
    Rebold N; Lagnf AM; Alosaimy S; Holger DJ; Witucki P; Mannino A; Dierker M; Lucas K; Kunz Coyne AJ; El Ghali A; Caniff KE; Veve MP; Rybak MJ
    Microbiol Spectr; 2023 Feb; 11(1):e0264722. PubMed ID: 36622246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
    Zhou H; Buetti N; Pérez-Galera S; Bravo-Ferrer J; Gutiérrez-Gutiérrez B; Paniagua-García M; Feifel J; Sauser J; Kostyanev T; Canton R; Tan LK; Basoulis D; Pintado V; Roilides E; Dragovac G; Torre-Cisneros J; Mediç D; Akova M; Goossens H; Bonten M; Harbarth S; Rodriguez-Baño J; De Kraker MEA;
    J Antimicrob Chemother; 2024 Sep; 79(9):2132-2141. PubMed ID: 38988305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
    Lee GC; Lawson KA; Burgess DS
    Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
    Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
    Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-acquired infections due to carbapenem-resistant
    Sharma S; Pramanik S; Marndi P; Banerjee T
    Indian J Med Res; 2023 Aug; 158(2):145-150. PubMed ID: 37787258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey.
    Palaiopanos K; Krystallaki D; Mellou K; Kotoulas P; Kavakioti CA; Vorre S; Vertsioti G; Gkova M; Maragkos A; Tryfinopoulou K; Paraskevis D; Tsiodras S; Zaoutis T
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):11. PubMed ID: 38273402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Risk Factors for Healthcare-Associated Infections Caused by Carbapenem-Resistant
    Sultan AM; Seliem WA
    Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e75-e80. PubMed ID: 29666685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.